You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
維亞生物(01873.HK):朗華製藥的環境影響報吿書獲批准
格隆匯 01-27 22:07

格隆匯 1 月 27日丨維亞生物(01873.HK)宣佈,公司非全資附屬公司浙江朗華製藥有限公司("朗華製藥")最近收到來自台州市生態環境局的回覆,內容有關公司擬生產若干醫藥中間體及原料藥而發出的朗華製藥環境影響報吿書。

該回覆批准了朗華製藥的方案,即根據環境影響報吿書所載的條款及計劃在浙江省化學原料藥基地臨海園區建立三個生產廠房及改造兩個現有廠房,以生產七種醫藥中間體,年產能合共超過300噸,及生產包括地瑞那韋在內的十二種原料藥,年產能合共超過350噸。

朗華製藥擬落實環境影響報吿書所載的生產計劃,並遵照該回覆提出的相關要求以及相關法律及法規對項目進行管理,力爭在可行情況下儘快投產。

生產計劃預期將促進集團業務增長、增加其生產能力及產能,從而使集團獲益。 

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account